Estée Lauder shares are rising as the market continues to digest the company’s fiscal third-quarter 2026 report and improved full-year outlook issued on May 1, 2026. The move is being reinforced by follow-through on analyst commentary this week, including UBS raising its price target to $85 from $75 on May 4, 2026 while keeping a neutral rating.

In its fiscal Q3 2026 release, Estée Lauder reported net sales of about $3.71 billion and adjusted EPS of $0.91, alongside improved profitability (including an adjusted operating margin cited at 15.0%). Management also increased and narrowed FY2026 expectations, with full-year organic sales growth guided to roughly +1% to +3% and EPS expectations broadly framed around the mid-$2 range, supporting the view that earnings power is stabilizing versus the prior downcycle.

Investors are treating the quarter as confirmation that cost actions and mix improvements can translate into margin recovery. The company has also highlighted restructuring actions and a focus on improving operating performance, which can amplify earnings sensitivity if demand trends hold, particularly in categories like fragrance and in regions showing better momentum.

Traders will watch for additional analyst revisions following the May 1 results, any updates on FY2026 execution against the raised targets, and signs that demand improvements are broadening beyond pockets of strength. With the stock near the new $85 UBS target, the next leg higher likely depends on further estimate increases or clearer evidence that growth and margin gains are sustainable into the next quarters.